• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

    5.430 +0.290 (+5.64%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 11, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 605,380
    Open 5.140
    Bid (Size) 5.220 (1)
    Ask (Size) 5.440 (3)
    Prev. Close 5.140
    Today's Range 5.054 - 5.440
    52wk Range 4.700 - 10.99
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Future of Healthcare: 10 Predictions For The Next Decade
    The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
    Via MarketMinute
    Topics Artificial Intelligence
    Exposures Artificial Intelligence COVID-19
    MindMed Announces New Employee Inducement Grants
    From Mind Medicine Inc.
    Via Business Wire

    Performance

    YTD
    -28.0%
    -28.0%
    1 Month
    -14.3%
    -14.3%
    3 Month
    -21.6%
    -21.6%
    6 Month
    +5.0%
    +5.0%
    1 Year
    -50.2%
    -50.2%

    More News

    Read More
    New Study Shows Ibogaine Can Be Made Without Using Plant Matter
    Via Investor Brand Network
    Why Mind Medicine Stock Is Skyrocketing Today
    Via The Motley Fool
    Why Mind Medicine Stock Is Soaring Today
    Via The Motley Fool
    Study Finds That the Mental Wellbeing Effects of Psilocybin Vary by Race
    Via Investor Brand Network
    MindMed Appoints Matt Wiley as Chief Commercial Officer
    From Mind Medicine Inc.
    Via Business Wire
    Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish
    Via Stocktwits
    MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
    From Mind Medicine Inc.
    Via Business Wire
    MindMed to Present at Leerink’s Global Healthcare Conference 2025
    From Mind Medicine Inc.
    Via Business Wire
    Warren Buffett's State of the Market
    Via The Motley Fool
    Groups of Military Veterans Urge Congress to Expedite Research on Psychedelics
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    Earnings Scheduled For March 6, 2025
    Via Benzinga
    MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
    From Mind Medicine Inc.
    Via Business Wire
    Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
    Via Stocktwits
    RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
    Via Investor's Business Daily
    MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
    From Mind Medicine Inc.
    Via Business Wire
    MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
    From Mind Medicine (MindMed) Inc.
    Via Business Wire
    Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish
    Via Stocktwits
    This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
    Via Benzinga
    MindMed to Be Added to the Nasdaq Biotechnology Index
    From Mind Medicine (MindMed) Inc.
    Via Business Wire
    MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
    From Mind Medicine (MindMed) Inc.
    Via Business Wire
    MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
    From Mind Medicine
    Via Business Wire
    MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
    From Mind Medicine Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Mind Medicine (MindMed) Inc. - Common Shares publicly traded?
    Yes, Mind Medicine (MindMed) Inc. - Common Shares is publicly traded.
    What exchange does Mind Medicine (MindMed) Inc. - Common Shares trade on?
    Mind Medicine (MindMed) Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Mind Medicine (MindMed) Inc. - Common Shares?
    The ticker symbol for Mind Medicine (MindMed) Inc. - Common Shares is MNMD on the Nasdaq Stock Market
    What is the current price of Mind Medicine (MindMed) Inc. - Common Shares?
    The current price of Mind Medicine (MindMed) Inc. - Common Shares is 5.430
    When was Mind Medicine (MindMed) Inc. - Common Shares last traded?
    The last trade of Mind Medicine (MindMed) Inc. - Common Shares was at 04/11/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.